In ₹ Crore except Per Share Latest Annual | GUFICBIO FY26 | RPGLIFE FY26 | UNICHEMLAB FY26 | GUJTHEM FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 66.84× | 153.76× | ◆ 14.76× | — | 84.26× -21% | |
| P/B | 6.45× | 7.59× | ◆ 1.37× | 16.28× | 7.59× -15% | |
| EV/EBITDA | 30.48× | 29.80× | ◆ 21.23× | 64.11× | 29.80× +2% | |
| Market Cap | ₹4,290 Cr | ₹4,597 Cr | ₹3,731 Cr | ₹4,685 Cr | ₹4,597 Cr -7% | |
| Growth | ||||||
| Revenue CAGR 3Y | — | — | 17.91% | — | 17.91% | |
| Revenue CAGR 5Y | — | — | 12.26% | — | 12.26% | |
| Revenue YoY (latest Q) | 16.58% | — | 20.13% | ◆ 22.07% | 21.10% -21% | |
| Net Income YoY (latest Q) | 70.71% | — | ◆ 496.08% | 22.12% | 259.10% -73% | |
| Profitability | ||||||
| EBITDA Margin | 16.03% | 20.79% | 8.36% | ◆ 45.55% | 20.79% -23% | |
| Net Income Margin | 6.80% | 16.28% | 11.48% | ◆ 28.15% | 16.28% -58% | |
| Return on Common Equity | 9.66% | ◆ 19.02% | 9.30% | 16.22% | 16.22% -40% | |
| Return on Capital Employed | 14.61% | ◆ 19.86% | 2.07% | 14.76% | 14.76% -1% | |
| Return on Assets | 4.78% | ◆ 14.52% | 6.77% | 9.27% | 9.27% -48% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.58× | ◆ 0.03× | 0.17× | 0.56× | 0.17× +241% | |
| Interest Coverage | 3.29× | ◆ 141.13× | 1.87× | 21.23× | 21.23× -85% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹944 Cr | ₹708 Cr | ₹2,202 Cr | ₹166 Cr | ₹708 Cr +33% | |
| Net Income | ₹64.2 Cr | ₹115 Cr | ₹253 Cr | ₹46.7 Cr | ₹115 Cr -44% | |
| Total Assets | ₹1,342 Cr | ₹793 Cr | ₹3,737 Cr | ₹503 Cr | ₹793 Cr +69% | |
| EPS | ₹6.4 | ₹18.08 | ₹35.91 | ₹0 | ₹18.08 -65% | |
| Book Value per Share | ₹66.31 | ₹366.07 | ₹386 | ₹26.41 | ₹366.07 -82% | |